← Leaderboards
Corinne Mary Linardic
Duke University
$9,533,807
Attributed
$13,917,141
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.7M · FY2009–25$20M$15M$10M$5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,412,858 · 9
By mechanism
U54$12,991,434 · 6
UM1$4,597,865 · 1
R01$1,413,474 · 1
K12$1,410,085 · 1
Top collaborators
- Christopher M Counter5 shared
- Ann M Reed5 shared
- Alex B Burgin2 shared
- Alexandra E Gould2 shared
- Angela Nicole Koehler2 shared
- Daniel Nomura2 shared
Most similar at Duke University
Same institution · by research overlap
- Herbert Kim Lyerly$48,598,090
- Michael Barry Kastan$65,974,699
- Robert M Califf$60,661,909
- Jeffrey None Crawford$10,066,024
- Oliver Michael Colvin$5,510,946
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsFoxo1a GeneOncogenicPax3 GeneMalignant Childhood NeoplasmIn VivoChimeric ProteinsStructureAlveolar RhabdomyosarcomaValidationRhabdomyosarcomaChildhoodMediatingTumorigenesisBindingProgramsChromatinMolecularScientistCell LineIn VitroResearch PersonnelChildFusion Oncogene Proteins
Grant awards (25)
Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma$2,271,313
UM1 · FY2025 · CA
Duke Center for Advancement of Child Health (CAtCH)$314,280
K12 · FY2025 · HD
Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma$2,326,552
UM1 · FY2024 · CA
Duke Center for Advancement of Child Health (CAtCH)$289,454
K12 · FY2024 · HD
Duke Center for Advancement of Child Health (CAtCH)$177,791
K12 · FY2023 · HD
Proteasomal recruiters of PAX3-FOXO1 Designed via Sequence-Based Generative Models$157,719
U54 · FY2023 · CA · contact PI
Defining and targeting the PAX3-FOXO1 interactome$157,719
U54 · FY2023 · CA · contact PI
Screening for Cys-Reactive Ligands to Target PAX3-FOXO1$369,418
U54 · FY2022 · CA · contact PI
Duke Center for Advancement of Child Health (CAtCH)$314,280
K12 · FY2022 · HD
Chemical probe discovery for PAX3-FOXO1$195,920
U54 · FY2022 · CA · contact PI
Defining and targeting the PAX3-FOXO1 interactome$173,498
U54 · FY2022 · CA · contact PI
Duke Center for Advancement of Child Health (CAtCH)$314,280
K12 · FY2021 · HD
Administrative Core$80,500
U54 · FY2020 · CA · contact PI
Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcoma$80,500
U54 · FY2020 · CA · contact PI
Administrative Core$38,133
U54 · FY2020 · CA · contact PI
Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcoma$38,133
U54 · FY2020 · CA · contact PI
Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcoma$5,849,947
U54 · FY2019 · CA · contact PI
Defining and targeting the PAX3-FOXO1 interactome$3,547,523
U54 · FY2019 · CA · contact PI
Chemical probe discovery for PAX3-FOXO1$1,509,861
U54 · FY2019 · CA · contact PI
Administrative Core$792,563
U54 · FY2019 · CA · contact PI
Molecular Modeling of Pediatric Skeletal Muscle Tumors$265,634
R01 · FY2013 · CA · contact PI
Molecular Modeling of Pediatric Skeletal Muscle Tumors$282,590
R01 · FY2012 · CA · contact PI
Molecular Modeling of Pediatric Skeletal Muscle Tumors$282,590
R01 · FY2011 · CA · contact PI
Molecular Modeling of Pediatric Skeletal Muscle Tumors$291,330
R01 · FY2010 · CA · contact PI
Molecular Modeling of Pediatric Skeletal Muscle Tumors$291,330
R01 · FY2009 · CA · contact PI